Genrix (Shanghai) Biopharmaceutical Co., Ltd.
25
8
12
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 25 trials
100.0%
+13.5% vs industry average
32%
8 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (25)
A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma
Role: lead
A Study of GR1803 in Systemic Lupus Erythematosus
Role: lead
A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps
Role: lead
A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.
Role: lead
A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2303 in Healthy Adult
Role: lead
A Study to Evaluate the Safety of GR2301 Injection in Healthy Volunteers.
Role: lead
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Role: lead
Phase I Trial of GR1803 Injection in Patients With RRMM
Role: lead
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
Role: lead
GR1803 Injection in Patients With RRMM
Role: lead
GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma
Role: lead
A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).
Role: lead
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma
Role: lead
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
Role: lead
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
Role: lead
Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis
Role: lead
Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE
Role: lead
Study to Evaluate GR1801's Efficacy and Safety
Role: lead
The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers
Role: lead
A Study to Evaluate the Safety, Immunogenicity, and Pharmacokinetics of GR2102 in Healthy Adult
Role: lead